NCT01915303 Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease Status TERMINATED Phase PHASE2
NCT01912872 Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma Status TERMINATED Phase PHASE4
NCT01911936 A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01911507 INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01911325 Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients Status TERMINATED Phase PHASE1
NCT01910441 Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients Status TERMINATED Phase PHASE4
NCT01908816 An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. Status COMPLETED Phase PHASE3
NCT01904214 A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function Status COMPLETED Phase PHASE1
NCT01902173 Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01900782 Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo. Status WITHDRAWN Phase PHASE3
NCT01900600 Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP) Status COMPLETED Phase NA
NCT01892722 Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01892436 Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01890746 A Safety and Efficacy Study of Eltrombopag in Subjects With AML Status COMPLETED Phase PHASE2
NCT01888432 Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants Status COMPLETED Phase PHASE3
NCT01883362 Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML Status COMPLETED Phase PHASE2
NCT01876368 Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan Status COMPLETED Phase PHASE3
NCT01874340 Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis Status TERMINATED Phase PHASE2